TY  - JOUR
AU  - Fernandez, O.
AU  - Arroyo, R.
AU  - Martinez-Yelamos, S.
AU  - Marco, M.
AU  - Garcia Merino, J. A.
AU  - Munoz, D.
AU  - Merino, E.
AU  - Roque, A.
PY  - 2016
DO  - 10.1371/journal.pone.0160313
SN  - 1932-6203
UR  - http://hdl.handle.net/10668/19153
T2  - Plos one
AB  - The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart (R) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN)...
LA  - en
PB  - Public Library of Science
KW  - Disease-modifying therapies
KW  - Injection-site reactions
KW  - Ms
KW  - Multicenter
KW  - Tolerability
KW  - Interferons
KW  - Progression
KW  - Prevalence
KW  - Trial
KW  - Drugs
TI  - Long-Term Adherence to IFN Beta-1 alpha Treatment when Using RebiSmart (R) Device in Patients with Relapsing-Remitting Multiple Sclerosis
TY  - research article
VL  - 11
ER  -